Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Ltd. has reported that First Sentier Investors no longer qualifies as a substantial holder as of June 28, 2024. This change follows a series of adjustments in voting interests by First Sentier Investors and its associates. A detailed schedule of the associated companies and their changes was provided in the announcement dated July 2, 2024.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
